![\"Screen](\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2017\/06\/Screen-Shot-2017-06-02-at-9.46.03-AM.png\")
<\/a><\/p>\n\n
<\/p>\n
NEW FILINGS<\/span><\/strong><\/p>\n Company: Byline Bancorp, Inc.<\/strong> Company: Esquire Financial Holdings<\/strong> Company: Mersana Therapeutics, Inc.<\/strong> Company: Blue Apron Holdings, Inc.<\/strong> Company: Tintri, Inc.<\/strong> Company: Aileron Therapeutics, Inc.<\/strong> Company: Dova Pharmaceuticals, Inc.<\/strong> TERMS ADDED<\/span><\/strong><\/p>\n Company: Athenex, Inc.<\/strong> IPO Boutique keeps apprised of the active pipeline. Currently there are 61 active IPOs in the pipeline as of June 2, 2016. No SPACs or Unit Offerings are included. NEW FILINGS Company: Byline Bancorp, Inc. Symbol: BY Description: They are a bank holding company headquartered in Chicago, Illinois and conduct all our business activities[…]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[24],"tags":[1239,1235,1238,1232,1233,1234,1236],"class_list":["post-2284","post","type-post","status-publish","format-standard","hentry","category-ipo","tag-alrn","tag-aprn","tag-atnx","tag-by","tag-esq","tag-mrsn","tag-tntr"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/2284","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=2284"}],"version-history":[{"count":5,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/2284\/revisions"}],"predecessor-version":[{"id":2298,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/2284\/revisions\/2298"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=2284"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=2284"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=2284"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\nSymbol: BY
\nDescription: They are a bank holding company headquartered in Chicago, Illinois and conduct all our business activities through our subsidiary, Byline Bank, a full service commercial bank.
\nTrade Date: TBD
\nUnderwriter(s): BofA Merrill Lynch, Keefe Bruyette & Woods
\nCo-Manager(s): Piper Jaffray, Sandler O\u2019Neill + Partners, Stephens Inc.
\nFiled: 5-31-17
\nListed Cash Raise: $75m<\/p>\n
\nSymbol: ESQ
\nDescription: They are a bank holding company headquartered in Jericho, New York and registered under the Bank Holding Company Act of 1956, as amended (the BHC Act).
\nTrade Date: TBD
\nUnderwriter(s): Sandler O’ Neill + Partners
\nFiled: 5-31-17
\nListed Cash Raise: $40.25m<\/p>\n
\nSymbol: MRSN
\nDescription: They are a clinical stage biopharmaceutical company focused on developing antibody drug conjugates, or ADCs, that offer a clinically meaningful benefit for cancer patients with significant unmet need.
\nTrade Date: TBD
\nUnderwriter(s): J.P. Morgan, Cowen and Company, Leerink Partners, Wedbush PacGrow
\nFiled: 6-1-17
\nListed Cash Raise: $75m<\/p>\n
\nSymbol: APRN
\nDescription: Blue Apron was founded in 2012 premised on a simple desire\u2014our founders wanted to cook at home with their families, but they found grocery shopping and menu planning burdensome, time consuming, and expensive.
\nTrade Date: TBD
\nUnderwriter(s): Goldman Sachs & Co., Morgan Stanley, Citigroup, Barclays
\nCo-Manager(s): RBC Capital Markets, SunTrust Robinson Humphrey, Stifel, Canaccord Genuity, Needham & Company, Oppenheimer & Co., Raymond James, William Blair
\nFiled: 6-1-17
\nListed Cash Raise: $100m<\/p>\n
\nSymbol: TNTR
\nDescription: Their mission is to provide large organizations and cloud service providers with an enterprise cloud platform that offers public cloud capabilities inside their own data centers and that can also connect to public cloud services.
\nTrade Date: TBD
\nUnderwriter(s): Morgan Stanley, BofA Merrill Lynch, Pacific Crest Securities
\nCo-Manager(s): Needham & Company, Piper Jaffray, Raymond James, William Blair
\nFiled: 6-1-17
\nListed Cash Raise: $100m<\/p>\n
\nSymbol: ALRN
\nDescription: They are a clinical-stage biopharmaceutical company that is focused on developing and commercializing a novel class of therapeutics called stapled peptides.
\nTrade Date: TBD
\nUnderwriter(s): BofA Merrill Lynch, Jefferies
\nCo-Manager(s): William Blair, Canaccord Genuity
\nFiled: 6-2-17
\nListed Cash Raise: $69m<\/p>\n
\nSymbol: DOVA
\nDescription: They are a pharmaceutical company focused on acquiring, developing and commercializing drug candidates for diseases that are treated by specialist physicians, with an initial focus on addressing thrombocytopenia, a disorder characterized by a low blood platelet count.
\nTrade Date: TBD
\nUnderwriter(s): J.P. Morgan, Jefferies, Leerink Partners
\nFiled: 6-2-17
\nListed Cash Raise: $74.75m<\/p>\n
\nSymbol: ATNX
\nDescription: They are a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer.
\nShares: 6 million
\nPrice Range: $11.00-$13.00
\nTrade Date: 6\/14
\nUnderwriter(s): Credit Suisse, Deutsche Bank Securities, J.P. Morgan
\nCo-Manager: ICBC International
\nTerms Added: 6-02-17<\/p>\n","protected":false},"excerpt":{"rendered":"